FDMT 8-K 2026-07-20

4D Molecular Therapeutics, Inc. (FDMT) 8-K dated 2026-07-20 — accession 0001193125-26-308409. This URL is the filing, not the FDMT hub.

4D Molecular Therapeutics, Inc. (FDMT) is a biotechnology company listed on US.

4D Molecular Therapeutics, Inc. filed a 8-K on 2026-07-20. Accession 0001193125-26-308409.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported FDMT revenue for 2026-06-30 was $6.8M. Net income was -$141.7M. FDMT currently screens at market cap $518.1M.

Not investment advice. The FDMT SEC hub lists recent forms. The stock page is the research view.